Logo for FT News podcast

Google’s parent company Alphabet is teaming up with British drug company GlaxoSmithKline to invest in bioelectronics. The aim is to treat diseases by targeting the electronic signals that pass along the body’s nerves. Chris Nuttall discusses the prospects for this new branch of medicine with the FT’s Science editor Clive Cookson

Get alerts on when a new story is published

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.

Follow the topics in this podcast